“Healthy adults seem to have terrific immunity from the initial two-dose series but, over time, that immunity may wane, resulting in increased risk of minor breakthrough infection at first and maybe more significant infection later — regardless of a variant driving the need for more variant-specific immunity,” she said.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.